A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy

[1]  Jay R. Harris,et al.  Patients with early breast cancer benefit from effective axillary treatment , 2005, Breast Cancer Research and Treatment.

[2]  Mark C Kelley,et al.  Lymphatic mapping and sentinel lymphadenectomy for breast cancer. , 2004, American journal of surgery.

[3]  Sunil J Rao,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .

[4]  D. Reintgen,et al.  Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes. , 2002, American journal of surgery.

[5]  I. Treilleux,et al.  Axillary lymph-node dissection for positive sentinel nodes in breast cancer patients. , 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  M. Kattan,et al.  Comparisons of nomograms and urologists' predictions in prostate cancer. , 2002, Seminars in urologic oncology.

[7]  S. Jaffer,et al.  Predictors of nonsentinel lymph node metastasis in breast cancer patients. , 2002, American journal of surgery.

[8]  M. Prasad,et al.  Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. , 2001, American journal of surgery.

[9]  A. Luini,et al.  Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma , 2001, Cancer.

[10]  P. V. van Diest,et al.  Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. , 2001, Archives of surgery.

[11]  K. Bland.  Characteristics of the Sentinel Lymph Node in Breast Cancer Predict Further Involvement of Higher-Echelon Nodes in the Axilla—Invited Critique , 2001 .

[12]  D. Reintgen,et al.  Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. , 2001, Archives of surgery.

[13]  K. McMasters,et al.  Predicting the status of the nonsentinel axillary nodes: a multicenter study. , 2001, Archives of surgery.

[14]  H. Cody,et al.  Lymphovascular Invasion Enhances the Prediction of Non-Sentinel Node Metastases in Breast Cancer Patients With Positive Sentinel Nodes , 2001, Annals of Surgical Oncology.

[15]  H. Cody,et al.  Clinical aspects of sentinel node biopsy , 2001, Breast Cancer Research.

[16]  Frank E. Harrell,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .

[17]  A. Giuliano,et al.  Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node , 2000, Cancer.

[18]  A E Giuliano,et al.  Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  A. Cantor,et al.  Do Cytokeratin-Positive-Only Sentinel Lymph Nodes Warrant Complete Axillary Lymph Node Dissection in Patients with Invasive Breast Cancer? , 2000, The American surgeon.

[20]  S. Gapstur,et al.  Factors associated with axillary lymph node metastasis from breast carcinoma , 1999, Cancer.

[21]  J. Donohue,et al.  Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  A E Giuliano,et al.  Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? , 1999, Annals of surgery.

[23]  E. Conant,et al.  Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma , 1999, Cancer.

[24]  A. Luini,et al.  Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. , 1999, Journal of the National Cancer Institute.

[25]  R. Orr.  The Impact of Prophylactic Axillary Node Dissection on Breast Cancer Survival—A Bayesian Meta-Analysis , 1999, Annals of surgical oncology.

[26]  A. Giuliano,et al.  Sentinel Node Metastasis in Patients with Breast Carcinoma Accurately Predicts Immunohistochemically Detectable Nonsentinel Node Metastasis , 1999, Annals of Surgical Oncology.

[27]  R. Foster,et al.  The sentinel node in breast cancer--a multicenter validation study. , 1998, The New England journal of medicine.

[28]  H. Cody,et al.  Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. , 1998, Journal of the American College of Surgeons.

[29]  M. Fan,et al.  Lymph node micrometastases from breast carcinoma , 1997, Cancer.

[30]  B. Cady,et al.  Case against axillary lymphadenectomy for most patients with infiltrating breast cancer , 1997, Journal of surgical oncology.

[31]  M. P. Moore,et al.  Axillary lymphadenectomy: A diagnostic and therapeutic procedure , 1997, Journal of surgical oncology.

[32]  A. Giuliano,et al.  Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. , 1997, Annals of surgery.

[33]  Umberto Veronesi,et al.  Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes , 1997, The Lancet.

[34]  A E Giuliano,et al.  Sentinel lymphadenectomy in breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  T. Yeatman,et al.  Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. , 1996, JAMA.

[36]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[37]  B. Asselain,et al.  Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer , 1992, The Lancet.

[38]  Donald E. Henson,et al.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989 .

[39]  M. Caleffi,et al.  The significance of local control in the primary treatment of breast cancer. Lucy Wortham James clinical research award. , 1987, Archives of surgery.